Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Outcome of HER2-amplified Metastatic Breast Cancer: A Retrospective Analysis

NCT02560311 is registered in ClinicalTrials.gov with University of Zurich as lead sponsor.

NCT NCT02560311
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02560311 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Outcome of HER2-amplified Metastatic Breast Cancer: A Retrospective Analysis
Lead sponsor
University of Zurich
Phase
Observational
Overall status
Unknown status
Start date
December 31, 2014
Completion date
February 29, 2016
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, erbb2, metastatic neoplasm